Perlmutter cancer center - Latest News Update, Information, Photos & Videos on Perlmutter cancer center at Lokmat Times

Women receiving standard treatment in New York City for ovarian, uterine, and cervical cancers are not at increased risk of being hospitalised for -- or dying from-- COVID-19 due to their cancer, a new study shows.The researchers found that neither having cancer nor receiving treatment for it, which can come with its own toxicities, worsened COVID-19 disease outcomes.Led by researchers at NYU Langone's Perlmutter Cancer Center and NYU Grossman School of Medicine, the study showed that 121 women, ages 51 to 63, who were receiving standard treatments for such malignancies and who contracted the pandemic coronavirus had similar rates of hospitalization and death as those who only had COVID-19.Publishing in the journal Cancer online July 31, the study showed that 54 per cent of the women (66 of 121) required hospitalization and among these, 25 per cent (17 of 66) died, for an overall death rate of 14 per cent. This is comparable to the results of another study, which showed a 21 per cent death rate among all 5,700 hospitalized patients with COVID-19 in the city, who were mostly male (60 per cent) and at greater risk of the disease, researchers say.Having late-stage gynecologic cancer, cancer surgery, or high-dose chemotherapy also did not increase a woman's risk of dying from COVID-19.Importantly, the work also found that 75 per cent of gynecologic cancer patients with COVID-19 had a mild form of the disease and recovered from their infection."Our study should be reassuring for women with gynecologic cancers who are worried that having cancer increases their risk of becoming seriously ill if they go to the hospital because of COVID-19," says study lead investigator Olivia Lara, MD, an oncology fellow in the Department of Obstetrics and Gynaecology at Perlmutter. These patients already contend with increased inflammation and imbalanced immune systems that, in theory, coronavirus infection could make worse."Women with gynecologic cancers have the same risk factors for dying from COVID-19 as women without these cancers," says study senior investigator Bhavana Pothuri, MD, MS, a professor in the Department of Obstetrics and Gynecology at Perlmutter.These shared risk factors, she says, which overall double women's risk of dying from COVID-19, are being African-American or having two or more underlying health conditions, such as hypertension, obesity, and diabetes.As part of the study, researchers reviewed the medical records of women treated for both COVID-19 and gynecologic cancer at area hospitals between March 1 and April 22, 2020. These included NYU Langone's Perlmutter Cancer Center, NYC Health + Hospitals Bellevue Hospital, Memorial Sloan-Kettering Cancer Center, Columbia University Medical Center, SUNY Downstate Medical Center, and the Montefiore Medical System.Another study finding was that a small number (eight of 121) of participants receiving immunotherapy, drugs that harness the immune system to attack cancer cells, were three times more likely to die than women who were receiving standard radiation, surgery, chemotherapy, or a combination of these therapies. However, Pothuri cautions that the number of women receiving immunotherapy was not large enough to lead to any firm recommendations about clinical care. (or to result in any firm conclusions about clinical care)Pothuri says the team has plans to analyze patient records for further insights into any factors that might lessen the impact of these underlying risk factors for COVID-19 on women with cancer, including how best to communicate with local community groups.For now, Pothuri says, women should definitely not put off screening, diagnosis, or treatment of new cancers out of any additional fear they have about the risks from COVID-19. "The basic rules of cancer care have not changed during the pandemic," she says. "Early detection, screening, and care lead to more people surviving what remains a leading cause of death among American women."( With inputs from ANI )

Home

City

Latest News

Cricket

LT Premium

National

International

Maharashtra

Opinions

Chhatrapati Sambhajinagar

Nagpur

Entertainment

Photos

Business

Technology

Sports

Lifestyle

Social Viral

Lokmat Games

Health

Lok Sabha Election 2024

Heatwave In India

Mumbai Water Cut

Maharashtra Lok Sabha Election

IPL 2024

Salman Khan

Perlmutter Cancer CenterFOLLOW

Perlmutter cancer center, Latest News

Health :Research finds link between drug resistance of leukaemia cells and mitochondria

Washington [US], April 27 : Leukemic cells often adopt features that let them evade the drugs' effects within a ... ...

Technology :Study suggests how immune cell leakage from tumours improve skin cancer treatment

Experiments on mice and human cells reveal that the number of specialised immune cells ready to combat skin cancer ... ...

Technology :Next-generation immunotherapy drug shows promise in some late-stage cancers

Initial study results prove that an experimental drug called 'nemvaleukin alfa' can be used to treat several types of late-stage cancer in some patients when used alone or in combination with another anticancer drug 'pembrolizumab.' ...

Health :Gene-based blood test for melanoma spread evaluates treatment progress: Study

A test that monitors blood levels of DNA fragments released by dying tumor cells may serve as an accurate early indicator of treatment success in people in the late stages of one of the most aggressive forms of skin cancer, a new study finds. ...

Health :Most women treated in New York City for gynecologic cancers not at increased risk of death from COVID-19: Study

Women receiving standard treatment in New York City for ovarian, uterine, and cervical cancers are not at increased risk of being hospitalised for -- or dying from-- COVID-19 due to their cancer, a new study shows. ...